1. Home
  2. XENE vs EXTR Comparison

XENE vs EXTR Comparison

Compare XENE & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • EXTR
  • Stock Information
  • Founded
  • XENE 1996
  • EXTR 1996
  • Country
  • XENE Canada
  • EXTR United States
  • Employees
  • XENE N/A
  • EXTR N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • EXTR Telecommunications Equipment
  • Sector
  • XENE Health Care
  • EXTR Telecommunications
  • Exchange
  • XENE Nasdaq
  • EXTR Nasdaq
  • Market Cap
  • XENE 2.4B
  • EXTR 2.4B
  • IPO Year
  • XENE 2014
  • EXTR 1999
  • Fundamental
  • Price
  • XENE $32.63
  • EXTR $17.07
  • Analyst Decision
  • XENE Strong Buy
  • EXTR Strong Buy
  • Analyst Count
  • XENE 11
  • EXTR 7
  • Target Price
  • XENE $54.82
  • EXTR $18.57
  • AVG Volume (30 Days)
  • XENE 1.5M
  • EXTR 1.2M
  • Earning Date
  • XENE 08-07-2025
  • EXTR 08-06-2025
  • Dividend Yield
  • XENE N/A
  • EXTR N/A
  • EPS Growth
  • XENE N/A
  • EXTR N/A
  • EPS
  • XENE N/A
  • EXTR N/A
  • Revenue
  • XENE $7,500,000.00
  • EXTR $1,089,717,000.00
  • Revenue This Year
  • XENE N/A
  • EXTR $3.47
  • Revenue Next Year
  • XENE $253.71
  • EXTR $7.79
  • P/E Ratio
  • XENE N/A
  • EXTR N/A
  • Revenue Growth
  • XENE N/A
  • EXTR N/A
  • 52 Week Low
  • XENE $26.74
  • EXTR $10.10
  • 52 Week High
  • XENE $46.00
  • EXTR $19.24
  • Technical
  • Relative Strength Index (RSI)
  • XENE 51.18
  • EXTR 46.81
  • Support Level
  • XENE $31.22
  • EXTR $17.83
  • Resistance Level
  • XENE $33.51
  • EXTR $18.81
  • Average True Range (ATR)
  • XENE 1.18
  • EXTR 0.43
  • MACD
  • XENE 0.04
  • EXTR -0.18
  • Stochastic Oscillator
  • XENE 45.62
  • EXTR 11.22

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides cloud networking solutions and industry services and support. Extreme designs, develops, and manufactures wired, wireless, and software-defined wide area-network (SD- WAN) infrastructure equipment, software and cloud-based network management solutions. The company's cloud solution is a single platform that offers unified network management of wireless access points, switches, and SD-WAN. The company operates in a single segment which develops and markets network infrastructure equipment. Roughly half of the firm's revenue is generated in the Americas, with the rest coming from Europe, the Middle East, Africa, and Asia-Pacific.

Share on Social Networks: